GSK reports positive data for experimental blood cancer drug
The DREAMM-1 study of patients with relapsed/refractory multiple myeloma confirmed the potential effectiveness of the medicine
Author
CCRH to organise international convention on World Homoeopathy Day
The convention will deliberate on linking education and clinical practice with research
IndiaRF invests $144 million in Panacea Biotec
Investment to be used for one-time settlement with existing lenders, working capital and growth requirements
Bayer Animal Health launches Seresto in India
Seresto is designed to deal with the vagaries of climate change and the resultant rise in temperatures across the globe that makes…
Zydus Cadila gets US FDA nod to market generic anti-epileptic tablets
The drug will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad
Evonik Catalysts expands production of activated metal catalysts in India
The new state-of-the-art production facility allows Evonik to fully utilise its capacities in Dombivli while establishing…
Syngene International, BIRAC set up CAPS
The collaboration is part of National Biopharma Mission
Syngene International announced the opening of its Centre for Advanced…
Sun Pharma launches ready-to-infuse INFUGEM in the US
INFUGEM (gemcitabine in sodium chloride injection) is the first and only chemotherapy product in a premixed, ready-to-infuse…
Biocon to soon expand its presence in biosimilars in US market
Dr Mazumdar Shaw, CMD, Biocon said that women must be encouraged to become entrepreneurs
Emcure launches generic Eribulin for treatment of metastatic breast cancer
The drug will be available in India at approximately 40 per cent cost of the innovator brand